CannPal Animal Therapeutics Limited (ASX: CP1) is a listed animal health company developing innovative and naturally derived plant-based therapeutic products for pets targeting the endocannabinoid system that owners can trust are both safe and scientifically validated.
The company has a research focus on cannabinoids, the active pharmaceutical ingredients extracted from the cannabis plant, to provide veterinarians and pet own...
CannPal Animal Therapeutics Limited (ASX: CP1) is a listed animal health company developing innovative and naturally derived plant-based therapeutic products for pets targeting the endocannabinoid system that owners can trust are both safe and scientifically validated.
The company has a research focus on cannabinoids, the active pharmaceutical ingredients extracted from the cannabis plant, to provide veterinarians and pet owners with clinically validated and standardised therapeutics to treat animals in a safe and ethical way.
CannPal has identified a significant opportunity to benefit from the rapidly growing medical cannabis.
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.